AzTrials
AzTrials

Total Hip Arthroplasty (THA)iPATHNCT07135843

Digital Home-Based Physical Activity Promotion for Older Adults After Total Hip Arthroplasty

A study testing Digital exercise program and Personal coaching for physical activity promotion in people with Total Hip Arthroplasty (THA) and Older Adults (65 Years and Older), run by Heidelberg University at 1 site in Germany.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the efficacy of a 12-week digital home-based intervention program, consisting of a tablet-based exercise program with or without personal coaching, to promote physical activity (PA) in older adults after total hip arthroplasty (THA). Read more about this study

Who is it for?
Ages 65 years and older
What is being tested?
Digital exercise program and Personal coaching for physical activity promotion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
213 participants
Where
1 siteGermany
Study dates
Sep 2025to Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age ≥65 years
  • Coxarthrosis with indication for total hip arthroplasty
  • Residence within a radius of ≤50 km from Heidelberg
  • Ability to walk ≥10 m (with/without walking aid)
  • Access to the internet (Wi-Fi) at home
  • Written informed consent

Who cannot join

  • Insufficient German language skills
  • Insufficient hearing to communicate via (video) telephone
  • Insufficient vision to recognize study materials
  • Contralateral coxarthrosis with indication for total hip arthroplasty
  • Severe medical condition illnesses that compromise physical fitness (heart failure classified as New York Heart Association [NYHA] class ≥3, heart valve defects associated with syncope, cardiac arrhythmia with dizziness, chronic obstructive pulmonary disease [COPD] with oxygen therapy, cancer with chemotherapy and/or radiation, Parkinson's disease with rollator use [Hoehn \& Yahr stage ≥4])
  • Living in a nursing home
Show all 9Show fewer
  • Planned major medical procedure within the next 6 months with inpatient hospital stay (e.g., further surgery)
  • Simultaneous participation in another competing study
  • Cognitive impairment (6-item Cognitive Impairment Test [6CIT] score >7 points)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Germany1 site, 1 recruiting
  • Department of Orthopaedics, Heidelberg University Hospital

    Heidelberg, Baden-Wurttemberg, 69118

    Tobias Reiner, Priv.-Doz. Dr. med., +49 (0)6221 25000, tobias.reiner@med.uni-heidelberg.de

    Recruiting

Other trials in Germany

About this study

Official title: iPATH - Digital Home-Based Training for Physical Activity Promotion in Older Adults After Total Hip Arthroplasty: A Randomized Controlled Trial

The goal of this clinical trial is to evaluate the efficacy of a 12-week digital home-based intervention program, consisting of a tablet-based exercise program with or without personal coaching, to promote physical activity (PA) in older adults after total hip arthroplasty (THA). The main question it aims to answer is:

  • Does the combination of the digital exercise program and personal coaching lead to higher PA six months after THA compared to usual care among older adults?
Read more

Secondary questions are:

  • Does the digital exercise program alone lead to higher PA compared to usual care?
  • Does the digital exercise program combined with personal coaching lead to higher PA compared to the exercise program alone?

Participants' PA will be objectively measured with a body-fixed sensor at 1 week before THA (T1), 6 weeks after THA (T2), and 6 months (i.e. after THA (T3). After the postoperative assessment at T2, participants will be randomly assigned to one of three groups:

  • 12-week tablet-based exercise program at home with virtual personal coaching for physical activity promotion
  • 12-week tablet-based exercise program at home
  • Usual care (control group, no additional intervention)
Read the detailed description

Hip osteoarthritis is common in older adults and is associated with limitations in activities of daily living, mobility, and quality of life. THA effectively reduces pain and improves physical functioning. However, patients often show no or only minimal increase in their typically low preoperative PA after THA. This lack of PA improvements may result from short rehabilitation periods, persistent sedentary habits, and methodological limitations of PA monitoring methods that focus mainly on frequency or temporal parameters (e.g. step count, walking or active durations).

Digital home-based training programs offer an opportunity for patients to continue structured exercises independently and at flexible times, extending postoperative care beyond standard rehabilitation. In addition, personal coaching that applies behavioral change techniques (BCTs) such as goal setting, action planning, self-monitoring with feedback, and barrier identification and management, may help break sedentary habits and promote PA. Recent advances in wearable sensor technology and processing algorithms now also enable a more detailed monitoring of real-world digital mobility outcomes (DMOs), allowing also capturing spatial-related parameters (e.g., walking distance, stride length, gait speed).

The iPATH study is a three-armed, assessor-blinded, randomized, parallel-group clinical trial evaluating the efficacy of two 12-week digital home-based intervention programs to promote PA in 213 older adults after THA:

  1. Digital exercise program with personal coaching (Intervention Group 1)
  2. Digital exercise program without personal coaching (Intervention Group 2)
  3. Usual care (Control Group) - no additional intervention

Outcome assessments are conducted at 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3; operationally defined as 26 weeks after THA). Randomization occurs after the T2 assessment, which typically coincides with the end of standard inpatient or outpatient rehabilitation. The digital home-based exercise program in the two intervention arms is based on the Keep-On-Keep-Up (KOKU) app, which includes progressive strength and balance exercises to be performed three times per week. Personal coaching includes three virtual sessions designed to promote PA behavior change using BCTs (goal setting, action planning, self-monitoring and feedback [activity tracker], barrier identification and management). Participants in the control group also receive a tablet but have no access to the KOKU app and do not receive any personal coaching sessions.

The primary outcomes are the mean daily step count (first) and mean daily walking distance (second), derived from a body-fixed sensor attached to the participant's lower back for a maximum measurement period of 7 consecutive days using the newest validated processing alogorithms. Secondary outcomes include additional DMOs (e.g., walking duration, number of walking bouts, walking speed, stride length, cadence), life-space mobility, physical capacity, hip pain and function, psychological and cognitive factors (e.g., concerns about falling, executive functioning), falls, intervention adherence and acceptability, health-related resource use, intervention delivery costs, and safety.

The primary study hypothesis is that the combination of the digital exercise program and personal coaching will lead to higher PA six months after THA compared to usual care. Secondary hypotheses are that (1) the digital exercise program alone will increase PA compared to usual care, and (2) the combination of the digital exercise program and personal coaching will increase PA compared to the digital exercise program alone.

Being tested
Digital exercise program, Personal coaching for physical activity promotion
Keywords
Total Hip Arthroplasty, Physical Activity, Older Adults, Digital Intervention, Physical Exercise, Coaching, Patient Education, Postoperative Care, Ambulatory Monitoring, Behavior Change
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital exercise programBehavioural

    KOKU is a digital adaptation of the evidence based Otago Exercise Program and Falls Management Exercise program, both designed to improve strength, balance, and reduce fall risk in older adults. KOKU includes 26 balance and strength exercises of varying difficulty. Each exercise is accompanied by written and audio instructions for safe performance and is demonstrated by a virtual trainer. Training sessions consist of three exercises suggested by the KOKU app, which participants are encouraged to perform for as many repetitions as possible until fatigue. Progression is guided by the participant's subjective assessment of effort and difficulty. Participants may choose to perform any exercise at any time, regardless of the app-suggested sequence. The KOKU app also provides reminders to exercise if no activity is detected for two days.

  • Personal coaching for physical activity promotionBehavioural

    Personal coaching consists of three video calls conducted via the study tablet by staff trained in BCTs and motivational communication skills. Participants receive a low cost, wrist worn activity tracker during the initial home visit to support self-monitoring and provide feedback on PA behavior. The first virtual coaching session (week 2) focuses on goal setting and action planning, the second session (week 3) addresses identification and management of barriers, and the third session (week 12) serves as a booster to review and adjust activity goals for the post intervention period.

Study groups in NCT07135843
Study groupRoleWhat they receive
Digital exercise program with personal coaching (Intervention Group 1)ExperimentalParticipants receive a tablet with the pre-installed training app KOKU, which delivers a 12-week standardized digital home-based strength and balance program. Participants are introduced to KOKU during an initial home visit and are encouraged to complete the program independently over the subsequent 12 weeks. In addition, they receive three individualized coaching sessions via video calls on the tablet during this period. To support self-monitoring and provide feedback on PA behavior - integrated into the BCTs used in the personal coaching - participants also receive a low-cost, easy-to-use wrist-worn activity tracker along with instructions on its use during the initial home visit.
Receives: Behavioral: Digital exercise program; Behavioral: Personal coaching for physical activity promotion
Digital exercise program without personal coaching (Intervention Group 2)ExperimentalParticipants receive a tablet with the pre-installed training app KOKU, which delivers a 12-week standardized digital home-based strength and balance program. Participants are introduced to KOKU during an initial home visit and are encouraged to complete the program independently over the subsequent 12 weeks. No personal coaching is provided.
Receives: Behavioral: Digital exercise program
Usual care (Control Group)No interventionParticipants receive a tablet without access to the KOKU app and do not receive any personal coaching sessions.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Daily step count

    Mean daily step count [#/day] is derived from a body-fixed sensor (AX6, Axivity Ltd.) attached to the participant's lower back for a maximum measurement period of 7 consecutive days, using validated processing algorithms.

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  2. Daily walking distance

    Mean daily cumulative walking distance [m/day] is derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

Secondary outcomes (24)
  1. Daily walking duration

    Mean daily walking duration [h/day] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  2. Daily walking bout count

    Mean daily walking bout count [#/day] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean daily walking bout count is determined for walking bouts >10 s, >30 s, and >60 s.

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  3. Daily-life walking bout duration

    Mean and 90th percentile daily-life walking bout durations [s] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  4. Daily-life walking speed

    Mean and 90th percentile daily-life walking speed [m/s] are derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean and 90th percentile walking speeds are determined for shorter walking bouts (10-30 s) and for longer walking bouts (>30 s).

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  5. Daily-life stride length

    Mean daily-life stride length [cm] is derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean stride length is determined for shorter (10-30 s) and longer (>30 s) walking bouts.

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  6. Daily-life stride duration

    Mean daily-life stride duration [s] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean stride duration is determined for all walking bouts and for longer walking bouts (>30 s).

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  7. Daily-life cadence

    Mean and 90th percentile daily-life cadence [steps/min] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean cadence is determined for all walking bouts and for longer walking bouts (>30 s), and the 90th percentile cadence for longer walking bouts (>30 s).

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  8. Daily-life walking variability

    Bout-to-bout variability [%] in walking bout duration, walking speed and stride length for longer walking bouts (>30 s), cadence and stride duration for all walking bouts, derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum of 7 consecutive days, based on validated processing algorithms.

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  9. Physical capacity (a)

    6-Minute Walk Test (instrumented with the mTEST³ system [mHealth Technologies srl, Bologna, Italy] to capture spatio-temporal gait parameters)

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  10. Physical capacity (b)

    Timed Up and Go (instrumented with the mTEST³ system [mHealth Technologies srl, Bologna, Italy] to measure durations of sit-to-walk, walking, turning, and sitting segments)

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  11. Physical capacity (c)

    30-Second Chair Stand Test

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  12. Physical capacity (d)

    4-Meter Gait Speed Test

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  13. Hip pain and function

    Oxford Hip Score

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  14. Life-space mobility

    University of Alabama at Birmingham Life-Space Assessment

    Measured: 1 week preoperatively (T1), and 6 months postoperatively (T3)

  15. Concerns about falling

    Short Falls Efficacy Scale-International

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  16. Health-related quality of life

    European Quality of Life 5 Dimensions 5 Level index

    Measured: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  17. Self-perceived health status

    EuroQol Visual Analogue Scale

    Measured: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  18. Change in self-perceived walking ability

    7-point Global Rating of Change Scale (1= markedly worse, 7 = markedly better)

    Measured: 6 weeks postoperatively (T2) and 6 months postoperatively (T3)

  19. Self-reported physical activity level

    University of California Los Angeles Activity Score

    Measured: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  20. Conscientiousness

    Conscientiousness dimension of Big Five Inventory-2

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  21. Exercise motivation

    Behavioural Regulation in Exercise Questionnaire

    Measured: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  22. Rate of falls

    Daily fall calendars

    Measured: From 6 weeks postoperatively (T2) to 6 months postoperatively (T3)

  23. Executive functioning

    Trail Making Test A \& B

    Measured: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  24. Health-related resource use

    Questionnaire for Health-Related Resource Use in an Elderly Population

    Measured: 1 week preoperatively (T1) and 6 months postoperatively (T3)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2025
  2. Study startSep 2025 (estimated)
  3. Primary completionJan 2028 (estimated)
  4. Study completionJan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized, controlled, assessor-blinded, three-arm parallel trial with a 12-week intervention period: (1) digital exercise program with personal coaching, (2) digital exercise program without personal coaching, and (3) control group (usual care).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
213 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07135843
Sponsor's protocol ID
S-324/2024
Other IDs
1DH2411155
Acronym
iPATH
Status last verified
Aug 2025
First submitted
7 Aug 2025
Last updated
2 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: In line with the principles of open science, anonymized individual participant data from the iPATH trial will be made available to qualified researchers after the primary evaluation has been completed and published. Data will be shared in a format that does not permit identification of individual participants and in full compliance with applicable data protection regulations (e.g., General Data Protection Regulation, EU data protection standards). Access to the data will be provided via a recognized open-access repository and require a formal application with a description of the proposed research project.

Publications

  • Buchner T, Knopf S, Haas AS, Eckert T, Fritz R, Merling M, Sander A, Klose C, Walker T, Bauer JM, Becker C, Werner C, Reiner T. Digital home-based physical activity promotion for older adults after total hip arthroplasty: protocol for the randomized controlled iPATH trial. BMC Geriatr. 2026 Jan 24;26(1):102. doi: 10.1186/s12877-026-07013-9.

    PubMed 41578219

Questions about this trial

What is this clinical trial studying?

A study testing Digital exercise program and Personal coaching for physical activity promotion in people with Total Hip Arthroplasty (THA) and Older Adults (65 Years and Older), run by Heidelberg University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tobias Eckert, PhD (+49 (0)6221 319 1562, tobias.eckert@med.uni-heidelberg.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Daily step count (time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07135843, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in